Efficacy of linezolid in a staphylococcal endocarditis rabbit model. 2001

M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
Pharmacology 7250-209-205, 301 Henrietta Street, Pharmacia Corporation, Kalamazoo, MI 49001, USA.

A rabbit endocarditis model was used to test the efficacy of oral linezolid and iv vancomycin. Twenty-four hours after catheter placement across the aortic valve, rabbits were infected with 3.5 x 10(6) cfu of Staphylococcus aureus (UC-9258). Two days after infection, control rabbits were killed, and treated rabbits were given 5 days of therapy with linezolid at 8 h intervals (tds) using either 25, 50 or 75 mg/kg/dose, or vancomycin at 12 h intervals (bd) using 25 mg/kg/dose. Linezolid at 75 and 50 mg/kg, and vancomycin significantly reduced S. aureus in aortic valve vegetations compared with the control. Linezolid at 25 mg/kg was ineffective. The efficacy of 75 and 50 mg/kg linezolid was related to maintenance of plasma drug levels near or above the linezolid MIC for UC-9258 (2 mg/L).

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D000069349 Linezolid An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract. Linezolide,N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,PNU-100766,U 100766,U-100766,Zyvox,100766, U,PNU 100766,PNU100766,U100766
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
December 2002, Antimicrobial agents and chemotherapy,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
September 2002, The Journal of antimicrobial chemotherapy,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
March 1987, Archives of ophthalmology (Chicago, Ill. : 1960),
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
August 2003, Antimicrobial agents and chemotherapy,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
March 2010, Journal of cataract and refractive surgery,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
January 2021, Experimental eye research,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
May 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
December 2018, Annals of clinical microbiology and antimicrobials,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
September 2007, Antimicrobial agents and chemotherapy,
M P Oramas-Shirey, and L V Buchanan, and C L Dileto-Fang, and C F Dailey, and C W Ford, and D H Batts, and J K Gibson
July 1952, Lancet (London, England),
Copied contents to your clipboard!